Thu, 15 Sep 2016
The problems at Marketfield aren't a microcosm of the liquid alts industry at large.
StockInvestor editor Paul Larson details recent changes to Morningstar's Wide Moat Focus Index, noting how the rally in wide-moat names could have them more fairly priced than lower-quality stocks.
Competitive advantages improved for one health-care firm, while a spin-off at another narrowed its moat, says Morningstar's Paul Larson in his discussion on recent moat-rating upgrades and downgrades.
A lot of companies are very well positioned regardless of how the fiscal cliff gets resolved, as long as it gets resolved, says Morningstar's Heather Brilliant.
Although U.S. markets are high and emerging markets have headwinds, these blue chips are great for investors with long time horizons, says StockInvestor editor Matt Coffina.
Starting from current valuations, stocks simply aren't capable of delivering double-digit annualized total returns, says Morningstar's Matt Coffina.
Adopting Buffett's very-long term perspective can help individual investors focus on what is important, says Morningstar's Paul Larson.
With dividend yields below long-run historical norms and the market overall looking pricey, growth in companies' intrinsic values will be key for stock investors, says Morningstar's Matt Coffina.
A willingness to look past short-term noise and instead focus on a company's competitive advantages and stewardship serves as a core stock-picking advantage for Morningstar's Matt Coffina.
©2014 Morningstar Advisor. All right reserved.